| Literature DB >> 6637330 |
F Laczi, J M Van Ree, L Balogh, A Szász, T Járdánházy, A Wágner, L Gáspár, Z Valkusz, I Dobranovics, J Szilárd.
Abstract
The effect of desglycinamide9-[Arg8]-vasopressin (DGAVP) on memory processes was studied in patients with Korsakoff's syndrome. Intranasal treatment with DGAVP for 7 days affected neither attention nor short- and long-term memories. It is suggested that treatment with DGAVP is not indicated for all types of memory disorders, and that the beneficial effect of this treatment may depend on the integrity of certain brain structures.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6637330 DOI： 10.1530/acta.0.1040177
Source DB: PubMed Journal: Acta Endocrinol (Copenh) ISSN： 0001-5598